Azvudine for the treatment of cancer patients with COVID-19: a multicenter, real-world, retrospective, cohort study

Abstract Background Cancer patients are at an elevated risk for SARS-CoV-2 infection and require vigilant monitoring. The efficacy and safety of Azvudine in treating COVID-19 among this vulnerable group remain under-researched. Methods We conducted a multicenter, retrospective cohort study of nine h...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Lei Li, Wenjie Liu, Ling Wang, Mengzhao Yang, Juan Wang, Guotao Li, Guowu Qian, Shixi Zhang, Donghai Liu, Hong Luo, Silin Li, Donghua Zhang, Zujiang Yu, Zhigang Ren
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2026-03-01
coleção:	BMC Cancer
Assuntos:	Cancer patients COVID-19 Azvudine All-cause death Composite disease progression
Acesso em linha:	https://doi.org/10.1186/s12885-026-15800-1
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!